Patient and health activists have raised questions about common chemical additives becoming ubiquitous in our environment, including triclosan and bisphenol A. The use of the biocide triclosan has increased exponentially…

FDA Approves First Combo Therapy for Advanced Melanoma The FDA has approved trametinib (Mekinist, GlaxoSmithKline) in combination with dabrafenib (Tafinlar, GlaxoSmithKline) to treat patients with advanced melanoma that is unresectable…

A Randomized, Double-blinded, Regimen-controlled, Phase II, Multicenter Study to Assess the Efficacy and Safety of Two Different Vismodegib Regimens in Patients With Multiple Basal Cell Carcinomas Sponsored by Hoffmann-La Roche,…

The primary reason patients seek aesthetic treatment from dermatologists or plastic surgeons is to combat the signs of aging.1 Increased interest in this goal has been driven by the development…

INTRODUCTION Poly-L-lactic acid (PLLA) (Figure 1)1 is a synthetic, biocompatible, biodegradable polymer that has been used in various medical applications for more than 3 decades. 1,2 For its use in…

INTRODUCTION Poly-L-lactic acid (PLLA) has been used in a variety of medical applications, such as absorbable sutures, fixation devices in orthopedic and plastic surgery, and vectors for sustained release of…

Introduction Injection-related adverse events (AEs) may occur with the use of any injectable substance, including all currently commercially available fillers. The most common of these AEs include discomfort, bruising, edema,…

INTRODUCTION There has been significant growth in both patient interest and physician use of soft tissue augmentation in recent years, especially among younger patients. Patients’ motivation behind this increased interest…

Introduction Poly-L-lactic acid (PLLA) was approved for use in Europe in 1999. In the United States, it was approved by the Food and Drug Administration in 2004 for the treatment…

It brings me great pleasure to introduce this edition of the JDD highlighting articles on skin cancer. I’d like to take this opportunity to make it personal – and share…

Basal cell carcinoma (BCC) is the most common human cancer.1 When detected early the vast majority of cases are successfully managed surgically, with 5-year cure rates exceeding 90%.2 Although rare,…